Nutritionally induced insulin resistance and receptor defect leading to beta-cell failure in animal models
- PMID: 10842665
- DOI: 10.1111/j.1749-6632.1999.tb07798.x
Nutritionally induced insulin resistance and receptor defect leading to beta-cell failure in animal models
Abstract
Animals with genetically or nutritionally induced insulin resistance and Type 2 diabetes comprise two groups: those with resilient beta-cells, e.g., ob/ob mice or fa/fa rats, capable of longstanding compensatory insulin hypersecretion and those with labile beta-cells in which the secretion pressure leads to beta-cell degranulation and apoptosis, e.g., db/db mice and Psammomys gerbils (sand rats). Psammomys features low insulin receptor density; on a relatively high energy diet it becomes hyperinsulinemic and hyperglycemic. In hyperinsulinemic clamp the hepatic glucose production is only partially suppressed by insulin, even in the normoglycemic state. The capacity of insulin to activate muscle and liver receptor tyrosine kinase is nearly abolished. GLUT4 content and mRNA are markedly reduced. Hyperinsulinemia was also demonstrated to inhibit insulin signaling and glucose transport in several other species. Among the factors affecting the insulin signaling pathway, phosphorylation of serine/threonine appears to be the prominent cause of receptor malfunction as inferred from the finding of overexpression of PKC epsilon isoforms in the muscle and liver of Psammomys. The insulin resistance syndrome progressing in animals with labile beta-cells to overt diabetes and beta-cell failure is a "thrifty gene" characteristic. This is probably also true for human populations emerging from food scarcity into nutritional affluence, inappropriate for their metabolic capacity. Thus, the nutritionally induced hyperinsulinemia, associated with PKC epsilon activation may be looked upon from the molecular point of view as "PKC epsilon overexpression syndrome."
Similar articles
-
Cellular mechanism of nutritionally induced insulin resistance: the desert rodent Psammomys obesus and other animals in which insulin resistance leads to detrimental outcome.J Basic Clin Physiol Pharmacol. 1998;9(2-4):347-85. doi: 10.1515/JBCPP.1998.9.2-4.347. J Basic Clin Physiol Pharmacol. 1998. PMID: 10212843
-
Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil.Diabetes Metab Res Rev. 2001 Jan-Feb;17(1):55-66. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr165>3.0.co;2-j. Diabetes Metab Res Rev. 2001. PMID: 11241892 Review.
-
Cellular mechanism of nutritionally induced insulin resistance in Psammomys obesus: overexpression of protein kinase Cepsilon in skeletal muscle precedes the onset of hyperinsulinemia and hyperglycemia.Diabetes. 2001 Mar;50(3):584-92. doi: 10.2337/diabetes.50.3.584. Diabetes. 2001. PMID: 11246878
-
Albert Renold memorial lecture: molecular background of nutritionally induced insulin resistance leading to type 2 diabetes--from animal models to humans.Int J Exp Diabetes Res. 2001;2(4):299-319. doi: 10.1155/edr.2001.299. Int J Exp Diabetes Res. 2001. PMID: 11795838 Free PMC article.
-
Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia.Diabetes Metab. 1996 Apr;22(2):122-31. Diabetes Metab. 1996. PMID: 8792092 Review.
Cited by
-
Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.Front Pharmacol. 2021 Nov 18;12:779962. doi: 10.3389/fphar.2021.779962. eCollection 2021. Front Pharmacol. 2021. PMID: 34867411 Free PMC article. Review.
-
Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet.Histochem Cell Biol. 2016 Jul;146(1):13-31. doi: 10.1007/s00418-016-1428-5. Epub 2016 Mar 28. Histochem Cell Biol. 2016. PMID: 27020567
-
Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II.J Clin Med. 2019 Aug 28;8(9):1332. doi: 10.3390/jcm8091332. J Clin Med. 2019. PMID: 31466386 Free PMC article. Review.
-
Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.Hum Mol Genet. 2009 Jul 1;18(13):2388-99. doi: 10.1093/hmg/ddp178. Epub 2009 Apr 21. Hum Mol Genet. 2009. PMID: 19386626 Free PMC article.
-
Adipokines and their potential impacts on susceptibility to myocardial ischemia/reperfusion injury in diabetes.Lipids Health Dis. 2024 Nov 13;23(1):372. doi: 10.1186/s12944-024-02357-w. Lipids Health Dis. 2024. PMID: 39538244 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous